19.04.2018
- European drugmakers GlaxoSmithKline of the UK and Novartis of Switzerland have agreed to contribute to a nearly $4 billion global research effort to fight drug-resistant strains of...
11.04.2018
- In an all-cash deal expected to close in the second half of this year, Swiss drugs giant Novartis has agreed to pay $8.7 billion for AveXis, a US-based clinical stage gene therapy...
28.03.2018
- In a move that may explain why GlaxoSmithKline last week turned thumbs down on bidding for Pfizer’s consumer drugs business, the UK’s largest drugmaker has announced plans to buy...
21.11.2017
- European pharmaceutical industry heavyweights Novartis and Bayer are challenging a proposal by parts of the UK’s National Health Service (NHS) to allow patients with wet age...
13.11.2017
- Amid estimates that the business could be worth as much as $1.5 billion, speculation is mounting that Swiss drugmaker Novartis may be planning to sell its dermatology generics arm...
18.10.2017
- As generics pricing pressure increases, Swiss drugmaker Novartis said it will close a US plant at Broomfield, Colorado, owned by its Sandoz subsidiary and employing 450 people. It...
07.09.2017
- Novartis CEO Joseph Jimenez has announced he will leave the Swiss-based drugnaker in early 2018, after eight years at the helm, and return to his native US. However, he will remain...
19.07.2017
- UK biopharma Oxford BioMedica has signed another major deal with Swiss drugmaker Novartis to supply lentiviral vectors used to create novel cell therapeutics, including CTL019...
